Medical Billing Services: AI Visibility Market Discovery Index

Benchmark Summary

Questions This Section Answers

• Which medical billing brand leads the benchmark, and by how much?
• Did the October 2026 leader's coverage change beyond normal variation?

athenahealth led the Medical Billing Services benchmark with valid recommendation coverage of 54.3% in October 2026, up from 50.3% in July 2026, within normal variation across the four-month series. The gap to the next closest brand was 15.7 percentage points, with Tebra (Kareo) at 38.6% in October 2026, down from 41.3% in July 2026.

Month-over-month, athenahealth recorded the largest increase, rising from 44.2% in September 2026 to 54.3% in October 2026, a change beyond normal month-to-month variation. AdvancedMD also rose beyond normal variation in the prior-to-current comparison, while no brand recorded a decline beyond normal month-to-month variation in October. Across the four months of the series, two brands registered increases in valid recommendation coverage beyond normal variation between July 2026 and October 2026, while one brand registered a comparable decline. The benchmark collected 800 prompt-surface observations in each month and produced 591 qualified observations in October 2026, up from 571 in July 2026, after qualification.

Current Benchmark at a Glance

Qualified surface breadth counts the canonical AI surface families with at least one qualified observation. The six families are ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode. Coverage movement during the intermediate months of August 2026 and September 2026 shifted several brands within the series before October's result.

For the strategic interpretation of this benchmark, read CiteWorks Studio's analysis of How AI Search Is Recommending Medical Billing Services

Research Scope and Qualification

Questions This Section Answers

• Why does the public benchmark use a smaller observation count than the raw collection?
• How many prompt-surface observations qualified for October 2026, and how does that compare to July?

The public benchmark is narrower than the raw collection universe by design.

Brand-level percentages use the qualified observations as the public denominator, not the raw collection. See the AI Visibility Market Discovery Methodology.

Current Brand Standings

Questions This Section Answers

• How does valid recommendation coverage differ across the top medical billing brands?
• Which brands combine broad presence with strong recommendation placement?

This table is the primary current-month benchmark view, sorted by valid recommendation coverage.

How to Read the Standings

• Presence rate: Share of qualified observations where the brand is mentioned at all.
• Valid recommendation coverage: Share of qualified observations where the brand appears in a valid recommendation, the primary benchmark metric.
• Top-three rate: Share of qualified observations where the brand is recommended in the top three positions.
• Rank-one rate: Share of qualified observations where the brand is recommended first.
• Net sentiment: Positive minus negative mentions, divided by total mentions. Ranges from -1 to 1.

For formulas and denominator rules, see AI Visibility Market Discovery Metric Definitions.

Recommendation Coverage Movement

Questions This Section Answers

• Which medical billing brands saw the largest coverage increases since July 2026?
• Which brand recorded the largest decrease in valid recommendation coverage?

Largest Increase: eClinicalWorks

eClinicalWorks rose 5.6 percentage points, moving from 22.2% valid recommendation coverage in July 2026 to 27.8% in October 2026, an increase beyond normal variation for the series. The brand moved up in each of the last two months, including a rise from 23.2% in September 2026 to 27.8% in October 2026. Presence rate also rose, from 49.9% in July 2026 to 61.1% in October 2026. Top-three rate rose from 6.8% to 11.2% and rank-one rate rose from 0.0% to 1.5% across the series. eClinicalWorks recorded 361 present observations in October 2026 and 164 valid recommendations.

Second-Largest Increase: R1 RCM

R1 RCM rose 4.2 percentage points, moving from 11.2% valid recommendation coverage in July 2026 to 15.4% in October 2026, an increase beyond normal variation for the series. The brand moved up in each of the last two months. Presence rate rose from 14.4% in July 2026 to 18.8% in October 2026, and top-three rate rose from 4.5% to 9.1%. Rank-one rate rose from 1.6% to 5.8%. R1 RCM recorded 111 present observations in October 2026 and 91 valid recommendations.

Category Leader: athenahealth

athenahealth remained the category leader with 54.3% valid recommendation coverage in October 2026, an increase beyond normal month-to-month variation from 44.2% in September 2026, and up from 50.3% in July 2026, within normal variation across the full series. Despite month-to-month swings, athenahealth widened its lead in every month of the series, with the gap growing from 29.3 points in July 2026 to 42.1 points in October 2026. Presence rate held roughly flat, from 89.3% in July 2026 to 91.5% in October 2026. Top-three rate rose from 36.4% to 41.6% and rank-one rate rose from 15.2% to 18.1% across the series. athenahealth recorded 541 present observations in October 2026 and 321 valid recommendations.

Stable Brands

AdvancedMD moved down from 40.3% valid recommendation coverage in July 2026 to 37.9% in October 2026, within normal variation, though it rose from 30.6% in September 2026 to 37.9% in October 2026, a change beyond normal month-to-month variation. Tebra (Kareo) moved down from 41.3% to 38.6%, within normal variation. DrChrono moved down from 28.9% to 24.4%, within normal variation, after rising in each of the last two months. CareCloud rose from 14.7% to 17.8%, within normal variation, extending an upward move across the last two months. Greenway Health rose from 1.8% to 3.0%, within normal variation. Medusind held flat at 0.2%. None of these movements clears the threshold for a durable trend.

Significant Decliner: CureMD

CureMD fell 8.8 percentage points, moving from 21.0% valid recommendation coverage in July 2026 to 12.2% in October 2026, a decline beyond normal variation for the series. The brand moved down in each of the three months since July 2026. Presence rate also declined, from 25.7% in July 2026 to 15.7% in October 2026. Coverage and presence both declined over the series. CureMD recorded 93 present observations in October 2026 and 72 valid recommendations. The gap between CureMD and eClinicalWorks widened by 14.4 points across the series, widening every month.

Recommendation Placement Snapshot

Questions This Section Answers

• Which medical billing brands are most often recommended in the top three positions?
• Can a brand have moderate coverage but still reach first-place recommendations?

Coverage alone does not show how prominently a brand is recommended. Placement rates reveal how often a recommended brand appears at the top of the answer. The following table shows the leading brands by coverage.

Similar coverage can still hide different first-position rates. athenahealth led on rank-one placement at 18.1% in October 2026, while R1 RCM, despite lower overall coverage of 15.4%, reached rank one in 5.8% of observations.

Buyer-Intent Distribution

Questions This Section Answers

• Do the qualified observations include pricing and multi-brand comparison questions?
• What buyer-intent class do all October 2026 qualified observations fall into?

The qualified observations for October 2026 all fell into the brand recommendation class.

The current public series measures only brand recommendation discovery and does not yet contain qualified observations in the pricing and value or multi-brand comparison classes.

Historical Measurement Record

This is an evergreen benchmark URL. New measurements are added to the same report.

Evidence and Source Layer

Questions This Section Answers

• What does a citation or source presence in the benchmark actually show?
• Does source presence prove what caused a recommendation?

The benchmark is built from prompt-level observations that retain the query, AI/search surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources. Source presence is evidence about the information environment. It is not automatically proof that the source caused the recommendation.

Scope Boundaries

• This public benchmark does not measure market share.
• It does not measure attributable sales.
• It does not measure every possible AI response.
• It does not measure organic-search ranking.
• It does not measure social mention volume.
• It does not measure private or sponsored channels.
• It does not establish causality from a metric movement alone.

Top 10 Cited Domains

Questions This Section Answers

• Which domains receive the most citations across AI platform answers?
• Are citations concentrated in a few domains or broadly distributed?

Across all AI platform responses in this measurement period, the benchmark observed 6,330 citations from 1,160 unique domains.

Citations are broadly distributed rather than concentrated in a few domains, with the top 10 domains accounting for a modest share of total citations. Two tracked brands' own domains appear in the top 10: advancedmd.com at rank 5 and athenahealth.com at rank 7. Review and software-comparison sites dominate the list, including softwarefinder.com, practicesuite.com, and definitivehc.com, alongside the two brand domains.

About This Benchmark

The LLM Authority Index AI Visibility Market Discovery Index tracks how often and how prominently brands appear in AI-generated answers across major AI and search surfaces. It is a neutral industry benchmark, updated monthly.

• AI Visibility Market Discovery Methodology
• AI Visibility Market Discovery Metric Definitions
• AI Visibility Market Discovery Research Standards
• Modeled AI Visibility Authority Value

Get a Company-Level Authority Index

The public industry benchmark shows category-level standings. The public percentages cannot identify the specific prompts, competitors, or underlying sources driving each brand's result. A company-level Authority Index can go deeper.

Get my free AI Company Index